News

Following a meeting with its CBD Initiative Scientific/Medical Advisory Board last November, the company has marked significant progress in readying its first natural CBD-based nutraceutical supplement for introduction

The research collaboration for Moderna will be managed by its venture company Valera, which is focused on the advancement of vaccines and therapeutics for the prevention and treatment

BASIS has been developed to support metabolic and cellular health, improve biological functions such as muscle repair and inflammatory response, and promote healthy aging with memory and cardiovascular

The drug is approved in combination with letrozole, to treat postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced breast cancer as initial endocrine-based

Orexin is one of the many neurotransmitters in the brain involved in promoting wakefulness, and Belsomra selectively blocks orexin receptors to suppress wake drive in the brain. The

Belviq will be marketed and distributed in South Korea by Ildong Pharmaceutical as part of its marketing and supply agreement with Arena’s wholly owned subsidiary, Arena Pharmaceuticals. In

Indicated to control high blood sugar in adults with type 1 and type 2 diabetes, Afrezza is a drug-device combination that uses a small and portable inhaler to

The trial’s primary objective is to evaluate the safety and tolerability of Lpathomab in subjects that are experiencing neuropathic pain. Patient enrollment is expected to start once the

NEPA is an oral fixed combination of a novel NK1receptor antagonist (netupitant) and the best-in-class 5-HT3receptor antagonist palonosetron, already approved in the USA with the trade name AKYNZEO